These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1696 related articles for article (PubMed ID: 18817506)

  • 21. Tumor-Progressive Mechanisms Mediating miRNA-Protein Interaction.
    Konishi H; Sato H; Takahashi K; Fujiya M
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The crosstalk between miRNAs and signaling pathways in human cancers: Potential therapeutic implications.
    Shekhar R; Kumari S; Vergish S; Tripathi P
    Int Rev Cell Mol Biol; 2024; 386():133-165. PubMed ID: 38782498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic microRNA strategies in human cancer.
    Li C; Feng Y; Coukos G; Zhang L
    AAPS J; 2009 Dec; 11(4):747-57. PubMed ID: 19876744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs in colorectal cancer: role in metastasis and clinical perspectives.
    Muhammad S; Kaur K; Huang R; Zhang Q; Kaur P; Yazdani HO; Bilal MU; Zheng J; Zheng L; Wang XS
    World J Gastroenterol; 2014 Dec; 20(45):17011-9. PubMed ID: 25493013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNAs in human cancer: from research to therapy.
    Negrini M; Ferracin M; Sabbioni S; Croce CM
    J Cell Sci; 2007 Jun; 120(Pt 11):1833-40. PubMed ID: 17515481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levels of MicroRNA Heterogeneity in Cancer Biology.
    Petrovic N; Ergün S; Isenovic ER
    Mol Diagn Ther; 2017 Oct; 21(5):511-523. PubMed ID: 28620889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated Analysis of miRNA and mRNA Endorses a Twenty miRNAs Signature for Colorectal Carcinoma.
    Angius A; Uva P; Pira G; Muroni MR; Sotgiu G; Saderi L; Uleri E; Caocci M; Ibba G; Cesaraccio MR; Serra C; Carru C; Manca A; Sanges F; Porcu A; Dolei A; Scanu AM; Rocca PC; De Miglio MR
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31434359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Revealing the role of miRNA-489 as a new onco-suppressor factor in different cancers based on pre-clinical and clinical evidence.
    Paskeh MDA; Mirzaei S; Orouei S; Zabolian A; Saleki H; Azami N; Hushmandi K; Baradaran B; Hashmi M; Aref AR; Ertas YN; Zarrabi A; Ashrafizadeh M; Samarghandian S
    Int J Biol Macromol; 2021 Nov; 191():727-737. PubMed ID: 34562537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA therapeutics: principles, expectations, and challenges.
    Rupaimoole R; Han HD; Lopez-Berestein G; Sood AK
    Chin J Cancer; 2011 Jun; 30(6):368-70. PubMed ID: 21627858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miRNA-214: expression, therapeutic and diagnostic potential in cancer.
    He H; Zhang H; Li Z; Wang R; Li N; Zhu L
    Tumori; 2015; 101(4):375-83. PubMed ID: 26108246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs and cancer therapy - from bystanders to major players.
    Braicu C; Calin GA; Berindan-Neagoe I
    Curr Med Chem; 2013; 20(29):3561-73. PubMed ID: 23834177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.
    Humphries B; Yang C
    Oncotarget; 2015 Mar; 6(9):6472-98. PubMed ID: 25762624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases.
    Li S; Liang Z; Xu L; Zou F
    Mol Cell Biochem; 2012 Jan; 360(1-2):147-58. PubMed ID: 21909994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-224: as a potential target for miR-based therapy of cancer.
    Chen W; Fan XM; Mao L; Zhang JY; Li J; Wu JZ; Tang JH
    Tumour Biol; 2015 Sep; 36(9):6645-52. PubMed ID: 26254100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNAs and cancer therapeutics.
    Yeung ML; Jeang KT
    Pharm Res; 2011 Dec; 28(12):3043-9. PubMed ID: 21773853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A step-by-step microRNA guide to cancer development and metastasis.
    Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E
    Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications.
    Ingenito F; Roscigno G; Affinito A; Nuzzo S; Scognamiglio I; Quintavalle C; Condorelli G
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signaling of miRNAs-FOXM1 in cancer and potential targeted therapy.
    Shi M; Cui J; Xie K
    Curr Drug Targets; 2013 Sep; 14(10):1192-202. PubMed ID: 23834153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer.
    Chakrabortty A; Patton DJ; Smith BF; Agarwal P
    Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 85.